Announcements Trials
Browse Landscape

Status

Completed 851Terminated 235Recruiting 131Unknown 116Withdrawn 71Active not recruiting 57Not yet recruiting 25Suspended 4No longer available 4Enrolling by invitation 2Available 1Approved for marketing 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 7Neuroblastoma 4Recurrence 3Prostatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Insulinoma 2Immunologic Deficiency Syndromes 2Hypoglycemia 2Hyperinsulinism 2Hematologic Neoplasms 2Typical Teratoid Rhabdoid Tumor 1Triple Negative Local Advanced Breast Cancer 1Thyroid Nodule 1Thalassemia 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oncology Patients With Gastroparesis 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Medulloblastoma 1Lymphoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × OTHER × Leukemia × Clear all
NCT03145545 2025-05-22

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

Children's Hospital of Philadelphia

Available
Other hematologic neoplasm

Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡